Skip to content
Screener

Bausch + Lomb BLCO Stock-Based Comp

Stock-Based Comp at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$458M+11.7%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$17.63M-6.1%
Glaukos logo
GlaukosGKOS
$28.87M+60.2%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$690K+5.5%
HRO
HarrowHROW
$3.84M-15.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$15.58M+49.0%

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total equity$6.4B-1.0%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
CapEx$71.0M-20.2%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$5.84B+17.0%
Enterprise value$10.54B+8.9%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001860742-26-000088
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Deferred income taxes(33)(91)
Gain on sale of assets(3)
Additions of accrued legal settlements56
Share-based compensation7258
Foreign exchange loss105
Gain excluded from hedge effectiveness(4)(6)
Loss on extinguishment of debt19
Amortization of inventory step-up resulting from acquisitions42

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's stock-based comp?
Bausch + Lomb (BLCO) reported stock-based comp of $38M in Q2 2026.
How has Bausch + Lomb's stock-based comp changed year-over-year?
Bausch + Lomb's stock-based comp increased by 26.7% year-over-year, from $30M to $38M.
What is the long-term trend for Bausch + Lomb's stock-based comp?
Over 4 years (2021 to 2025), Bausch + Lomb's stock-based comp has grown at a 24.5% compound annual growth rate (CAGR), from $62M to $149M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Bausch + Lomb's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude